Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial

The COPEP Study Team: Department of Infectious Diseases and Hospital Epidemiology. University of Basel. Basel, Switzerland / Division of Infectious Diseases. Geneva University Hospitals, Faculty of Medicine. Geneva, Switzerland / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chag...

Descripción completa

Detalles Bibliográficos
Autores: Labhardt, Niklaus D., Smit, Mikaela, Petignat, Ianis, Perneger, Thomas, Marinosci, Annalisa, Ustero, Pilar, Ribeiro, Maria Pia Diniz, Ragozzino, Silvio, Nicoletti, Giovanni Jacopo, Faré, Pietro Benedetto, Andrey, Diego O., Jacquerioz, Frederique, Lebowitz, Dan, Agoritsas, Thomas, Meyer, Benjamin, Spechbach, Hervé, Salamun, Julien, Guessous, Idris, Chappuis, François, Kaiser, Laurent, Decosterd, Laurent Arthur, Grinsztejn, Beatriz, Bernasconi, Enos, Cardoso, Sandra Wagner, Calmy, Alexandra
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:Brasil
Institución:Fundação Oswaldo Cruz (FIOCRUZ)
Repositorio:Repositório Institucional da FIOCRUZ (ARCA)
Idioma:inglés
OAI Identifier:oai:arca.fiocruz.br:icict/50471
Acceso en línea:https://arca.fiocruz.br/handle/icict/50471
Access Level:acceso abierto
Palabra clave:COVID-19
SARS-CoV-2
Lopinavir
Ritonavir
Post-exposure prophylaxis
Descripción
Sumario:The COPEP Study Team: Department of Infectious Diseases and Hospital Epidemiology. University of Basel. Basel, Switzerland / Division of Infectious Diseases. Geneva University Hospitals, Faculty of Medicine. Geneva, Switzerland / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica DST/AIDS. Rio de Janeiro, RJ, Brasil / Division of Infectious Diseases. Ospedale Regionale di Lugano and Faculty of Medicine.University of Southern -Switzerland. Lugano, Switzerland.

Similares en LA Referencia